Skip to main content
Premium Trial:

Request an Annual Quote

Allscripts' 2bPrecise to Provide NIH With Cloud-Based Software for Precision Medicine

NEW YORK (GenomeWeb) – 2bPrecise, a wholly owned subsidiary of Allscripts Healthcare, said today that it has launched an early-adopter program at the National Institutes of Health for its cloud-based genomics and precision medicine solution.

According to 2bPrecise, its cloud-based software uses advanced clinical-genomic ontology and data harmonization methods to combine genomic, clinical, and lifestyle information. The solution simplifies and optimizes the process of finding, selecting, ordering, and receiving genomic tests and it integrates with Allscripts' Sunrise Electronic Health Record system and other EHR systems enabling clinicians to use the results of sequencing tests at the point of care, 2bPrecise said.

Under the terms of the agreement, physicians and researchers at the National Human Genome Research Institute, the National Cancer Institute, and the NIH Clinical Center will use 2bPrecise's solution to improve patient diagnosis and advance medical research. Moving forward, the company intends to make the software broadly available to provider, integrated delivery network, and payer organizations who want "to advance the research that will unlock new insights of molecular diagnostics and new treatments," 2bPrecise General Manager Assaf Halevy said in a statement.

Financial and other terms of the agreement were not disclosed.